NCT05614492

Brief Summary

This study is designed to develop and test an individual decision aid for pre-exposure prophylaxis (PrEP) tailored to Black women who have been exposed to intimate partner violence and are working with a domestic violence service provider. three different ways of delivering the tailored decision aid are being tested: 1) as an individual tool; or 2) as a shared decision-making tool with a domestic violence advocate; as compared to generalized information. The goal of decision aid will be to address key cultural and structural factors affecting these women and can help them gain PrEP awareness and access.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at below P25 for not_applicable hiv

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

2.2 years

First QC Date

November 1, 2022

Last Update Submit

August 18, 2025

Conditions

Keywords

HIV PreventionTenofovir

Outcome Measures

Primary Outcomes (2)

  • Change in HIV Risk Perception

    8-item Perceived Risk of HIV scale repeated at the beginning and end of engagement with the decision aid, with responses measured on a 5- point Likert scale, which has been shown to be more robust than a single-item screening question for HIV risk perception. Specifically, responders will specify their level of agreement to the question in five points: (1) Strongly disagree; (2) Disagree; (3) Neither agree nor disagree; (4) Agree; (5) Strongly agree.

    Baseline and post intervention, up to 2 minutes

  • Change in Decisional preference for PrEP

    Single item screening question: "How interested are you in starting PrEP now?" repeated at the beginning and end of engagement with the decision aid, with responses measured on a 5- point Likert scale, with responders specify their level of agreement to the question in five points: (1) Strongly disagree; (2) Disagree; (3) Neither agree nor disagree; (4) Agree; (5) Strongly agree.

    Baseline and post intervention, up to 2 minutes

Secondary Outcomes (1)

  • Change in PrEP Uptake

    Month 1, Month 3, Month 6

Other Outcomes (4)

  • Change in Feelings of Decisional conflict

    Baseline, Month 1, Month 3, Month 6

  • Process Outcomes

    Month 6

  • Urine tenofovir levels

    Month 3

  • +1 more other outcomes

Study Arms (3)

Individual Arm (IDM)

EXPERIMENTAL

Self-administration of the intervention

Behavioral: Individual PrEP Decision Aid

Shared Arm (SDM)

EXPERIMENTAL

Advocate-administration of the intervention

Behavioral: Shared PrEP Decision Aid

Control Arm (Time and Attention Matched Control)

ACTIVE COMPARATOR

Self-administration of standard PrEP information from Centers for Disease Control (CDC).

Behavioral: CDC PrEP Video

Interventions

Participant engages with the decision support tool designed to optimize PrEP uptake among Black cisgender women who have experienced IPV independently. They also enter data independently.

Also known as: IDM
Individual Arm (IDM)
CDC PrEP VideoBEHAVIORAL

A video from the Centers for Disease Control and Prevention that provides basic, general information on PrEP

Also known as: Control
Control Arm (Time and Attention Matched Control)

Domestic violence service advocate (DVA) engages with the decision support tool designed to optimize PrEP uptake among Black cisgender women who have experienced IPV with the participant and enters data

Also known as: SDM
Shared Arm (SDM)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 years or older
  • self-identification as cisgender female
  • IPV-exposed (i.e., at least one physical, sexual, or psychological IPV victimization experience by a male partner) in the past 12 months
  • self-reported HIV negative
  • English- and/or Spanish-speaking
  • self-identify as Black or African American

You may not qualify if:

  • Currently using PrEP
  • Unable to provide consent
  • Participated in formative research for this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Springboard Community Services - Baltimore City Office

Baltimore, Maryland, 21209, United States

Location

MeSH Terms

Interventions

SDM

Study Officials

  • Tiara Willie, PhD, MA

    Johns Hopkins Bloomberg School of Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Parallel: Participants will be assigned to one of three groups in parallel for the duration of the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2022

First Posted

November 14, 2022

Study Start

May 10, 2023

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations